Pittsburgh, PA, United States of America

Samuel LoPresti

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: University of Pittsburgh. Active years: 2024.

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Samuel LoPresti in Biomaterials

Introduction

Samuel LoPresti is an accomplished inventor based in Pittsburgh, PA. He has made significant contributions to the field of biomaterials, particularly through his innovative research at the University of Pittsburgh. His work focuses on the decellularization and functionalization of extracellular matrix biomaterials, which has important implications for medical applications.

Latest Patents

Samuel LoPresti holds a patent for a method of preparing an extracellular matrix (ECM) material. This patent, titled "Decellularization and functionalization of extracellular matrix biomaterials," outlines a process that involves treating the ECM material with reactive oxygen species or reactive nitrogen species. The method not only details the preparation of the ECM material but also describes various methods of use for the resulting product. He has 1 patent to his name.

Career Highlights

Throughout his career, Samuel has been dedicated to advancing the understanding and application of biomaterials. His research has contributed to the development of new techniques that enhance the functionality of ECM materials, which are crucial for tissue engineering and regenerative medicine.

Collaborations

Samuel LoPresti collaborates with Bryan Nicklaus Brown, working together to push the boundaries of research in biomaterials. Their combined expertise fosters innovation and drives forward the potential applications of their findings.

Conclusion

Samuel LoPresti's work in the field of biomaterials exemplifies the impact of innovative research on medical science. His contributions through patents and collaborations continue to pave the way for advancements in tissue engineering and regenerative medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…